Screener
Standard BioTools Inc. LAB Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$20.1MMiss by $700.4K
EPS-$0.07Miss by $0.06
Revenue estimate$20.8M
EPS estimate-$0.01
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$18.8M
EPS estimate-$0.02
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Standard BioTools Inc. report Q2 2026 earnings?
- Standard BioTools Inc. (LAB) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Standard BioTools Inc.'s Q2 2026 revenue and EPS?
- Standard BioTools Inc. reported revenue of $20.1M and eps of $-0.07 for Q2 2026.
- Did Standard BioTools Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $20.8M by $700.4K. EPS missed the consensus estimate of $-0.01 by $0.06.
- How did Standard BioTools Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 7.6% from $21.8M a year earlier and eps declined 75.0% from $-0.04.
- Where can I find Standard BioTools Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-335106) and the 10-Q periodic report (0001193125-26-335103) directly on SEC EDGAR. The filing index links above go to sec.gov.
